LYTIR

Company · LTGO

Latigo Biotherapeutics, Inc.

Nasdaq's symbol directory lists LTGO on Nasdaq as “Latigo Biotherapeutics, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($2.5M); 6 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Tananbaum James B. bought on 1 day latest Aug 10, 2026 bought $2.5M
Every trade (1)
  1. BUYTananbaum James B. bought Aug 10, 2026 140,000 shares filing $2.5M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. AI Biotechnology LLC filed Nov 6, 2026 Schedule 13G/A passive filing 4.8%
  2. Westlake BioPartners Fund I, L.P. filed Oct 29, 2026 Schedule 13G passive filing 19.9%
  3. AI Biotechnology LLC filed Aug 18, 2026 Schedule 13G passive filing 5%
  4. RA CAPITAL MANAGEMENT, L.P. filed Aug 17, 2026 Schedule 13G passive filing 8.4%
  5. Foresite Capital Fund VI LP filed Aug 17, 2026 Schedule 13D may seek influence 2,203,800 shares filing 3.5%
  6. Deep Track Capital, LP filed Aug 13, 2026 Schedule 13G passive 4,445,656 shares filing 7.03%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Departure or appointment of directors or officers filing Nov 5, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.